Page last updated: 2024-08-21

quinazolines and Wallerian Degeneration

quinazolines has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kamijo, M; Matsuoka, N; Minoura, K; Mutoh, S; Shimoshige, Y; Takakura, S	1

Other Studies

1 other study(ies) available for quinazolines and Wallerian Degeneration

Article	Year
Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats. Brain research, 2009, Jan-09, Volume: 1247 Topics: Aldehyde Reductase; Animals; Axons; Cell Death; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Enzyme Inhibitors; Ganglia, Spinal; Male; Nerve Degeneration; Polymers; Quinazolines; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sural Nerve; Treatment Outcome; Wallerian Degeneration	2009

Article

Year

Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats.

Brain research, 2009, Jan-09, Volume: 1247

Topics: Aldehyde Reductase; Animals; Axons; Cell Death; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Enzyme Inhibitors; Ganglia, Spinal; Male; Nerve Degeneration; Polymers; Quinazolines; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sural Nerve; Treatment Outcome; Wallerian Degeneration

2009